Evotec SE. (EVO) NASDAQ
$7.15 (0.09) (-1.24%)
Market Cap: $2.57B
As of 04/18/24 04:30 PM EDT. Market closed.
Evotec SE. (EVO)
NASDAQ
$7.15
(0.09) (-1.24%)
Market Cap: $2.57B
As of 04/18/24 04:30 PM EDT. Market closed.
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture ... read more
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Peck Billy L. JR | EVP, Business Development | Nov 22, 2022 | Option Exercise | $0.00 | 5,022,987 | 502 | 5,522,987 | Aug 29, 2023, 04:42 PM |
Wheeler Ronald Scott | Chief Administrative Officer | Mar 24, 2020 | Option Exercise | $2.50 | 60,000 | 150,000 | 10,000 | Sep 03, 2021, 04:53 PM |
Wheeler Ronald Scott | Chief Administrative Officer | Feb 27, 2020 | Buy | $2.50 | 60,000 | 150,000 | 70,000 | Sep 03, 2021, 04:53 PM |
Abood Thomas J. | Director | Apr 16, 2018 | Buy | $2.50 | 120,263 | 300,658 | 126,856 | Oct 19, 2018, 08:48 AM |
Yeros John Peter | Chief Executive Officer | Apr 16, 2018 | Buy | $3.00 | 50,000 | 150,000 | 74,650 | Oct 17, 2018, 01:35 PM |
Owner | Relationship | Date | Value($) |
Peck Billy L. JR | EVP, Business Development | 11/22/2022 | 502 |
Wheeler Ronald Scott | Chief Administrative Officer | 03/24/2020 | 150,000 |
Wheeler Ronald Scott | Chief Administrative Officer | 02/27/2020 | 150,000 |
Abood Thomas J. | Director | 04/16/2018 | 300,658 |
Yeros John Peter | Chief Executive Officer | 04/16/2018 | 150,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 12,178 | 0% | 27.44% | Other |
Period of Report: 12/31/2022
10-K/10-Q Filings: View